Takeda Pharmaceutical Non-GAAP EPS of ¥279.00, revenue of...

2025-10-30 03:17:02 ET More on Takeda Pharmaceutical Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules Transcript Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules - Slideshow Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually Innovent inks $11.4 billion cancer drug partnership with Japan's Takeda Trump's 100% drug tariffs send pharma stocks lower Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Non-GAAP EPS of ?279.00, revenue of ?2219.5B; updates FY outlook